Skip to main content
Premium Trial:

Request an Annual Quote

David Cameron in the Lab

As part of a UK initiative announced today to sequence up to 100,000 patients within the National Health System, Prime Minister David Cameron popped by the genomics core facility at the Cancer Research UK Cambridge Research Institute.

James Hadfield, who runs the lab, says on his blog that it was "a little nerve wracking having my boss, his boss and his boss's boss standing by while I was talking to the country's boss."

As reported by our sister publication, GenomeWeb Daily News, the UK government has set aside £100 million ($160.9 million) to sequence up to 100,000 people and use their genomic information to help treat and to study cancer and other diseases. Sequencing will be voluntary and patients will be able to opt out at any time.

Hadfield says that Cameron asked him how easy is it to sequence a genome today, so he decided the best demonstration would be to have him do it himself.

"We prepared a cartridge and flowcell ready to go. The Prime Minister took the sample through the set-up screen, waited for the flow check and kicked of the run by pressing start," proving that sequencing is so easy that "even political leaders can do it."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.